Dexcom Announces Upcoming Conference Presentation

Rhea-AI Summary

DexCom, Inc. (NASDAQ:DXCM) announces that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 10:30 AM (EST). The presentation aims to provide an update on the company's ongoing efforts in diabetes care technology. Interested parties can access the webcast through the Dexcom Investor Relations website, where it will also be archived for future viewing.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at 10:30am (EST).

Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005958/en/

DexCom, Inc.

Sean Christensen

Senior Director – Investor Relations and Corporate FP&A

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When is the DexCom presentation at the Canaccord Genuity 42nd Annual Growth Conference?

The DexCom presentation will take place on August 10, 2022, at 10:30 AM (EST).

Who will present at the Canaccord Genuity 42nd Annual Growth Conference for DXCM?

Jereme Sylvain, Executive Vice President and Chief Financial Officer of DexCom, will present.

Where can I watch the DexCom presentation from the conference?

The presentation can be watched on the Dexcom Investor Relations website and will be archived there for future reference.

What is the focus of DexCom's presentation at the conference?

The presentation will provide an update on DexCom's advancements in diabetes care technology.